Investment
Features
FeesSafety
Academy
More
Pluang+

Pfizer’s steady turnaround and high dividend make it a better retirement pick than Starbucks.

Market News
31 Aug 2026
24/7 Wall Street
View Source
Bullish
Pfizer’s steady turnaround and high dividend make it a better retirement pick than Starbucks.

Pfizer and Starbucks both raised their outlooks recently, but Pfizer's recovery is more advanced and income-focused investors benefit from its higher dividend yield of 6.2% compared to Starbucks' 2.3%. Pfizer’s earnings growth is already evident, while Starbucks shows strong sales momentum but less profit progress. For retirees needing reliable income, Pfizer’s cheaper valuation and dividend stability make it the preferred choice, despite some patent risks. Starbucks may suit younger investors with longer horizons.

More News (PFE)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App